As the days tick down to the inauguration of President-elect Joseph Biden and Vice President-elect Kamala Harris, what will be the priorities of the new administration when it comes to U.S. healthcare? Let’s take a look. Handling the COVID-19 pandemic…
When it comes to patient intervention programs to promote adherence, what are the best tactics? The right answer may be “all of them” – but it also depends on who is setting up the program. Pharmacies, payers, or pharmaceutical companies…
AllazoHealth CEO Clifford Jones and Chief Operating Officer William Grambley recently answered questions about patient intervention data: what it is, how clients employ it, and how AllazoHealth uses this data to accurately predict individual patient behavior. Is using patient intervention…
There are a lot of companies that claim they offer solutions that are powered by artificial intelligence (AI) and/or machine learning. But what exactly does that mean? AI and machine learning Artificial intelligence is a system that learns. It acquires…
For payers and pharmacists, designing an effective adherence program to support patients can be challenging, according to AllazoHealth’s William Grambley, COO, and Dr. Linda Schultz, VP, Clinical and Customer Success. Keeping these tips in mind can help. 1. Design your…
This year's election could have a major effect on adherence rates. Here are some possible changes in healthcare policy that could be enacted under Trump or Biden, and the impact on adherence. Revocation of the ACA In November, the Supreme…
The current model for medication therapy management (MTM), under Medicare Part D, is based on a set of minimum performance standards that all participating plans must meet to qualify for payment. However this model incentivizes plans to offer a minimum…
Polypharmacy, the simultaneous use of multiple drugs, is becoming more common as the population ages. More than 30% of older adults in the United States take five or more drugs, typically for multiple chronic conditions. How polypharmacy contributes to non-adherence…
Barriers to medication adherence can take the form of social determinants such as housing, employment and access to pharmacies – and systemic barriers such as pre-approvals, multiple prescriptions and affordability. But psychological barriers also play a major role. Understanding these…